• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Hamilton Lane downgraded by Goldman with a new price target

    1/6/25 8:11:18 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email
    Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00
    Get the next $HLNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    9/12/2024$156.00Equal Weight
    Wells Fargo
    4/11/2024$115.00Overweight → Neutral
    JP Morgan
    1/11/2024Outperform → Perform
    Oppenheimer
    5/26/2023$87.00Perform → Outperform
    Oppenheimer
    3/15/2023$85.00Neutral → Overweight
    JP Morgan
    8/9/2022$72.00 → $75.00Buy → Neutral
    UBS
    More analyst ratings

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Launches U.S. Venture Capital and Growth Evergreen Fund, Further Expanding its $10B+ AUM Evergreen Platform

      Fund offers access to private venture and growth investments including disruptive technologies and innovative businesses CONSHOHOCKEN, Pa., May 6, 2025 /PRNewswire/ -- Leading private markets investment firm Hamilton Lane (NASDAQ:HLNE) today announced the launch of the Hamilton Lane Venture Capital and Growth Fund ("HLVCG" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Act of 1940 ("40 Act"), available to accredited U.S. investor clients, including high-net-worth investors and their advisors2, as well as institutional investors. HLVCG offers investors in the U.S. access to the firm's global venture capital investment platform with what th

      5/6/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      11/13/24 4:31:06 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      4/2/25 4:33:42 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SCHEDULE 13D/A filed by Hamilton Lane Incorporated

      SCHEDULE 13D/A - Hamilton Lane INC (0001433642) (Subject)

      2/14/25 4:27:12 PM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane Incorporated filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Hamilton Lane INC (0001433642) (Filer)

      2/12/25 4:21:19 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    See more
    • Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

      Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

      4/23/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations

      Industry leader with 35+ years of experience in manufacturing operations and global supply chain excellence Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Vincent (Vin) Colicchio as Senior Vice President of Operations, effective February 3, 2025. In this role, Vin will lead Cosette's manufacturing, global supply chain, and operational strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250210366017/en/Senior Vice President, Operations (Photo

      2/10/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

      Experienced commercial leader joins Cosette to drive the next phase of growth and transformation Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette's generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250203104224/en/Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire) "Cosette is

      2/3/25 8:00:00 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider French River 5 Ltd claimed ownership of 480,015 shares and claimed ownership of 7 units of Class B Common Stock (SEC Form 3)

      3 - Hamilton Lane INC (0001433642) (Issuer)

      4/25/25 5:05:37 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Delgado-Moreira Juan was granted 34,031 shares, increasing direct ownership by 3% to 1,298,847 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 5:00:47 PM ET
      $HLNE
      Investment Managers
      Finance
    • Co-Chief Executive Officer Hirsch Erik R. was granted 36,001 shares and covered exercise/tax liability with 3,386 shares, increasing direct ownership by 37% to 120,275 units (SEC Form 4)

      4 - Hamilton Lane INC (0001433642) (Issuer)

      3/18/25 4:58:27 PM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Hamilton Lane upgraded by Oppenheimer with a new price target

      Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $186.00

      1/21/25 7:49:57 AM ET
      $HLNE
      Investment Managers
      Finance
    • Hamilton Lane downgraded by Goldman with a new price target

      Goldman downgraded Hamilton Lane from Neutral to Sell and set a new price target of $139.00

      1/6/25 8:11:18 AM ET
      $HLNE
      Investment Managers
      Finance
    • Wells Fargo initiated coverage on Hamilton Lane with a new price target

      Wells Fargo initiated coverage of Hamilton Lane with a rating of Equal Weight and set a new price target of $156.00

      9/12/24 7:41:15 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/13/24 9:56:40 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/12/24 3:55:46 PM ET
      $HLNE
      Investment Managers
      Finance
    • Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

      SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

      11/4/24 11:53:29 AM ET
      $HLNE
      Investment Managers
      Finance

    $HLNE
    Financials

    Live finance-specific insights

    See more
    • Hamilton Lane Incorporated to Announce Fourth Fiscal Quarter and Full Fiscal Year 2025 Results on May 29, 2025

      CONSHOHOCKEN, Pa., May 8, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2025 before the market opens on Thursday, May 29, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 11:00 a.m. ET on May 29 to discuss the results for the fourth fiscal quarter and full fiscal year. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://sharehold

      5/8/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families

      RED BANK, N.J., April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (NASDAQ:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families. This strategic acquisition enhances PAX Health's portfolio of mental health services and expands its geographic footprint in Western Pennsylvania, strengthening the company's ability to deliver high-quality psychiatric care across diverse

      4/17/25 8:27:00 AM ET
      $HLNE
      Investment Managers
      Finance
    • HAMILTON LANE INCORPORATED REPORTS THIRD QUARTER FISCAL 2025 RESULTS, WITH MANAGEMENT & ADVISORY FEES GROWING BY 11% AND ASSETS UNDER MANAGEMENT GROWING BY 12% YEAR-OVER-YEAR

      CONSHOHOCKEN, Pa., Feb. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the third fiscal quarter ended December 31, 2024. THIRD QUARTER FISCAL 2025 HIGHLIGHTS Assets under management – Total assets under management of $134.7 billion grew $14.8 billion year-over-year. Fee-earning assets under management increased $7.9 billion to $71.0 billion over the same period.Revenue – Management and advisory fees of $126.3 million for the quarter represent growth of 11% versus the prior year period.Carried Interest – Unrealized carried interest balance of approximately $1.3 billion, up 15% versus the prior year

      2/4/25 7:00:00 AM ET
      $HLNE
      Investment Managers
      Finance